From nonspecific to specific immunosuppression: facts and speculation.
D000818:Animals; D000906:Antibodies / Q000276:immunology; D000911:Antibodies, Monoclonal / Q000276:immunology; D001324:Autoantigens / Q000276:immunology; D001327:Autoimmune Diseases / Q000628:therapy; D001402:B-Lymphocytes / Q000276:immunology; D002478:Cells, Cultured; D004247:DNA / Q000276:immunology; D000939:Epitopes / Q000276:immunology; D005260:Female; D006241:Haptens / Q000276:immunology; D006801:Humans; D007108:Immune Tolerance; D007074:Immunoglobulin G / Q000276:immunology; D007165:Immunosuppression Therapy; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D007167:Immunotherapy; D008180:Lupus Erythematosus, Systemic / Q000276:immunology / Q000628:therapy; D008297:Male; D015122:Mercaptopurine / Q000627:therapeutic use; D051379:Mice; D009705:Nucleosides / Q000276:immunology; D013601:T-Lymphocytes / Q000276:immunology
D000906:Antibodies; D000911:Antibodies, Monoclonal; D001324:Autoantigens; D000939:Epitopes; D006241:Haptens; D007074:Immunoglobulin G; D007166:Immunosuppressive Agents; D009705:Nucleosides; D004247:DNA; D015122:Mercaptopurine